Home » Topics » BioWorld Science

BioWorld Science
RSS

ASIT Biotech publishes phase III data for gp-ASIT+ grass allergen peptide immunotherapy

Jan. 20, 2020

OXi-4503 in combination with ARA-C shows safety and early clinical efficacy in AML

Jan. 20, 2020

Novel muraminomicin derivatives with potent activity in MRSA infection models

Jan. 20, 2020

Sanofi initiates phase III study of SAR-408701 in CEACAM5-positive metastatic nonsquamous NSCLC

Jan. 20, 2020

Enrollment ongoing in phase I/II study of oral BDTX-189 in advanced solid tumors

Jan. 20, 2020

Clene opens phase II study of CNM-Au8 in ALS

Jan. 17, 2020

Amgen studies AMG-199 in patients with MUC17-positive gastric and GEJ cancer

Jan. 17, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

Researchers discover compound with potential for EZH2-driven cancers

Jan. 17, 2020

PGAM1 inhibitor HKB-99 reduces non-small cell lung cancer tumor growth in vivo

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...